N-Benzoylaminopurine

N-Benzoylaminopurine Basic information
Product Name:N-Benzoylaminopurine
Synonyms:6-BENZOYLAMINOPURINE;6-BENZAMIDOPURINE;N6-BENZOYLAMINOPURINE;N6-BENZOYLADENINE;N-BZ-ADE;N-BENZOYLADENINE;N-BENZOYLAMINOPURINE;N-Benzolaminopurine
CAS:4005-49-6
MF:C12H9N5O
MW:239.23
EINECS:629-048-6
Product Categories:Purine;Biochemicals and Reagents;Biochemistry;Nucleobases and their analogs;Nucleoside Analogs;Nucleosides, Nucleotides, Oligonucleotides;Nucleosides, Nucleotides & Related Reagents
Mol File:4005-49-6.mol
N-Benzoylaminopurine Structure
N-Benzoylaminopurine Chemical Properties
Melting point 242-244°C
density 1.494 g/cm3
storage temp. 2-8°C
Water Solubility Insoluble in water
solubility DMSO (Slightly), Methanol (Slightly)
form powder to crystal
pka11.98±0.20(Predicted)
color White to Almost white
BRN 20585
InChIInChI=1S/C12H9N5O/c18-12(8-4-2-1-3-5-8)17-11-9-10(14-6-13-9)15-7-16-11/h1-7H,(H2,13,14,15,16,17,18)
InChIKeyQQJXZVKXNSFHRI-UHFFFAOYSA-N
SMILESC(NC1=C2C(=NC=N1)NC=N2)(=O)C1=CC=CC=C1
CAS DataBase Reference4005-49-6(CAS DataBase Reference)
Safety Information
Hazard Codes Xn,Xi
Risk Statements 22-43
Safety Statements 36/37
WGK Germany 3
Hazard Note Irritant
HS Code 29335990
MSDS Information
ProviderLanguage
SigmaAldrich English
ALFA English
N-Benzoylaminopurine Usage And Synthesis
Chemical PropertiesWhite solid
UsesN6-Benzoyladenine is used in the organic synthesis of adenine derivative molecules such as bicyclic adenine nucleoside via a condensation reaction between L-threo-pentofuranose derivative 1 and 6-N-benzoyladenine and to produce oxy-peptide nucleic acids.
DefinitionChEBI: 6-Benzamidopurine is a member of purines.
Biochem/physiol ActionsN6-Benzoyladenine comprises of adenine moiety and is a potent inhibitor of bromodomain-containing protein 4 (BRD4). N6-Benzoyladenine modulates tumor necrosis factor α (TNF-α) levels. It elicits cytotoxicity in liver and ileum cancer cells and may serve as a potential candidate agent for cancer chemotherapy.
SynthesisBenzoyl chloride (1.3 mL, 11 mmol) was added dropwise over 30 min to a stirred suspension of adenine (1.35 g, 10 mmol) in dry pyridine, and stirring was continued at 100 °C for a further 3 h, and the reaction mixture was allowed to stand overnight at room temperature. The reaction was quenched with methanol and the solvents were removed under reduced pressure. The residue was triturated in hot isopropanol and dried in vacuo to give 8 as a white solid: yield 2.15 g (90%). MS (+ESI): m/z 240 [M+H]+; 1H NMR (400 MHz, d-DMSO): δ11.50 (s, 1H), 8.74 (s, 1H), 8.52 (s, 1H), 8.11 (d, 2H, J = 7.2 Hz), 7.66 (t, 1H, J = 7.2 Hz), 7.58 (t, 2H, J = 7.2 Hz).
N-Benzoylaminopurine synthesis.jpg
5'DIMETHOXYTRITYL DA(BZ)+DG(IBU)+DC(BZ)+T BETA-CYANOETHYL PHOSPHORAMIDITE FLUORESCEIN-N6-DATP N-BENZOYLADENOSINE 5'DIMETHOXYTRITYL DA(BZ)+DG(IBU) BETA-CYANOETHYL PHOSPHORAMIDITE 3'-DA CEP N6-ANISOYLADENOSINE 5'-O-(4,4'-DIMETHOXYTRITYL)-N6-BENZOYL-2'-DEOXYADENOSINE-3'-O-SUCCINIC ACID 5'DIMETHOXYTRITYL DA(BZ) BETA-CYANOETHYL PHOSPHORAMIDITE BZ-DMT-DEOXYADENOSINE 2-CLPH DIESTER TRIETHYLAMMONIUM SALT N-Benzoyl-5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]adenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite N6,3'-O-DIBENZOYL-2'-DEOXYADENOSINE AURORA 5003 AURORA 5004 5'-O-(4,4'-Dimethoxytrityl)-N6-benzoyl-2'-deoxyadenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite 5'-O-(4,4'-DIMETHOXYTRITYL)-N6-BENZOYL-R-ADENOSINE-3'-T-BUTYLDIMETHYLSILYL-2'-(2-CYANOETHYL-N,N-DIISOPROPYL)PHOSPHORAMIDITE N-Benzoylaminopurine N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine N6-Benzoyl-2'-deoxyadenosine

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.